The GCC & MENA Pharma M&A Advisory Firm
We sit at the intersection of capital and opportunity — advising investors evaluating pharmaceutical assets and owners exploring strategic transactions across Saudi Arabia, the GCC, and MENA.
Our Advisory Services
M&A Deal Advisory
Buy-side and sell-side pharma transaction support — target identification, deal structuring, and process management across KSA and the GCC.
Commercial Due Diligence
Pre-acquisition asset validation built for GCC pharma — NUPCO exposure, SFDA pipeline, key-person risk, and localization scoring.
Market Entry & Commercial Strategy
Ground-truth market intelligence and entry strategy for Saudi Arabia and the GCC — before you commit capital.
Post-Merger Integration Support
PMI advisory for MENA pharma transactions — helping protect NUPCO and distributor relationships and track synergy capture.
Commercial Feasibility & Launch Strategy
Business planning for pharma, nutraceutical, and cosmeceutical ventures in MENA — before you commit the capital.
Specialist pharmaceutical M&A advisory for Saudi Arabia, the GCC, and MENA.
Saudi Arabia Pharmaceutical Market Report 2026
Saudi Arabia Pharmaceutical Market Intelligence Report 2026-2030
A strategic overview of market trends, localization initiatives, procurement dynamics, and growth opportunities in one of the region's most important pharmaceutical markets.
Why Work With PharmaBoard
✓ Exclusive focus on GCC and MENA pharma — not a generalist firm
✓ Deep understanding of NUPCO procurement and SFDA regulatory dynamics
✓ Both buy-side and sell-side — we understand what investors need and what owners want
✓ Local market intelligence that global CDD templates consistently miss
✓ Founded by a published pharma M&A author with 25 years of GCC & MENA pharma experience
Typical Mandates
Buy-side asset sourcing
Screening acquisition and in-licensing opportunities for international pharma and consumer-health groups, validated against market sales data and national drug registries.
Licensing-partner and manufacturer scouting
Identifying regional manufacturers and dossier holders for out-licensing, supply, and partnership agreements.
Expert market input
GCC and MENA pharma market perspective for strategy consulting and investment projects.
All engagements are conducted under strict confidentiality.
Markets & Sectors
Markets
Saudi Arabia
Egypt
GCC
MENA
Focus Areas
Pharmaceuticals
Manufacturing
Healthcare Investments
Market Access
Business Development
Let's Discuss Your Next Opportunity
Whether you are evaluating a market, exploring a manufacturing investment, assessing a product opportunity, or seeking strategic guidance, PharmaBoard can help.
Contact Us
Provide project details to receive a tailored engagement outline.